Antiviral Agents Concept

subject area of

• cTAZ : a safeguard factor of antiviral response  Journal Articles
• A Canadian Critical Care Trials Group project in collaboration with the international forum for acute care trialists - Collaborative H1N1 Adjuvant Treatment pilot trial (CHAT): study protocol and design of a randomized controlled trial  Journal Articles
• A Comparison of Respiratory Syncytial Viral Prophylaxis in Multiple Births versus Singletons in the Canadian Registry of Palivizumab  Journal Articles
• A Controlled Trial of Oral Acyclovir for Iridocyclitis Caused by Herpes Simplex Virus  Journal Articles
• A Decade of Respiratory Syncytial Virus Epidemiology and Prophylaxis: Translating Evidence into Everyday Clinical Practice  Journal Articles
• A Survey of Parental Knowledge of Respiratory Syncytial Virus and Other Respiratory Infections in Preterm Infants  Journal Articles
• A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS)  Journal Articles
• A meta-analysis of the effect of antibody therapy for the prevention of severe respiratory syncytial virus infection  Journal Articles
• A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo  Journal Articles
• A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29–35 weeks’ gestational age  Journal Articles
• A randomized study of alpha‐interferon plus ribavirin for 6 months or 12 months for the treatment of chronic hepatitis C in patients with bleeding disorders  Journal Articles
• A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)  Journal Articles
• A real-time dashboard of clinical trials for COVID-19  Journal Articles
• A review of cost–effectiveness of palivizumab for respiratory syncytial virus  Journal Articles
• ASK1 inhibitors are potential pan-antiviral drugs, which dampen replication of diverse viruses including SARS-CoV2  Journal Articles
• Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19  Journal Articles
• Activation and Inhibition of Virus and Interferon: The Herpesvirus Story  Journal Articles
• Acyclovir Prophylaxis to Prevent Herpes Simplex Virus Recurrence at Delivery: A Systematic Review  Journal Articles
• Adaptive immune responses fail to provide protection against genital HSV‐2 infection in the absence of IL‐15  Journal Articles
• Adherence and outcomes: a systematic review of palivizumab utilization  Journal Articles
• Adherence to Palivizumab for Respiratory Syncytial Virus Prevention in the Canadian Registry of Palivizumab  Journal Articles
• Adoption in Canada of an international risk scoring tool to predict respiratory syncytial virus hospitalization in moderate-to-late preterm infants  Journal Articles
• Adverse Effects of Amantadine and Oseltamivir Used During Respiratory Outbreaks in a Center for Developmentally Disabled Adults  Journal Articles
• Adverse Events Associated with High‐Dose Ribavirin: Evidence from the Toronto Outbreak of Severe Acute Respiratory Syndrome  Journal Articles
• An amantadine hydrochloride dosing program adjusted for renal function during an influenza outbreak in elderly institutionalized patients.  Journal Articles
• Angiotensin Blockade Does Not Affect Fibrosis Progression in Recurrent Hepatitis C After Liver Transplantation  Journal Articles
• Anti-Ebola therapy for patients with Ebola virus disease: a systematic review  Journal Articles
• Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial  Journal Articles
• Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis  Journal Articles
• Antimicrobial Nanomaterials and Coatings: Current Mechanisms and Future Perspectives to Control the Spread of Viruses Including SARS-CoV-2  Journal Articles
• Antiviral Agents for Influenza  Journal Articles
• Antiviral drug treatment for nonsevere COVID-19: a systematic review and network meta-analysis  Journal Articles
• Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus  Journal Articles
• Antivirals for influenza: a summary of a systematic review and meta-analysis of observational studies  Journal Articles
• Antivirals for post-exposure prophylaxis of influenza: a systematic review and network meta-analysis.  Journal Articles
• Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies  Journal Articles
• Antivirals for treatment of severe influenza: a systematic review and network meta-analysis of randomised controlled trials.  Journal Articles
• Application strategies of serum HBV DNA detection in HBV infection patients: A retrospective study of 5611 specimens.  Journal Articles
• Atypical clinical course in juvenile metachromatic leukodystrophy involving novel arylsulfatase A gene mutations  Journal Articles
• Burden of respiratory syncytial virus hospitalisation among infants born at 32–35 weeks' gestational age in the Northern Hemisphere: pooled analysis of seven studies  Journal Articles
• CARESS  Journal Articles
• CARESS: The Canadian Registry of Palivizumab  Journal Articles
• Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial  Journal Articles
• Challenges in the prevention or treatment of RSV with emerging new agents in children from low- and middle-income countries  Journal Articles
• Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies  Journal Articles
• Changing costs and the impact on RSV prophylaxis  Journal Articles
• Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: a retrospective cohort study  Journal Articles
• Chromatin Dynamics of Gene Activation and Repression in Response to Interferon α (IFNα) Reveal New Roles for Phosphorylated and Unphosphorylated Forms of the Transcription Factor STAT2  Journal Articles
• Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis  Journal Articles
• Cigarette Smoke Suppresses Type I Interferon-Mediated Antiviral Immunity in Lung Fibroblast and Epithelial Cells  Journal Articles
• Cigarette smoke attenuation of poly I:C-induced innate antiviral responses in human PBMC is mainly due to inhibition of IFN-β production  Journal Articles
• Clinical Issues and Research in Respiratory Failure from Severe Acute Respiratory Syndrome  Journal Articles
• Clinical features of external genital warts.  Journal Articles
• Clinical significance of periodic detection of hepatitis B virus YVDD mutation by ultrasensitive real-time amplification refractory mutation system quantitative PCR during lamivudine treatment in patients with chronic hepatitis B.  Journal Articles
• Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alfa‐2a plus ribavirin  Journal Articles
• Combined Corticosteroid and Antiviral Treatment for Bell Palsy  Journal Articles
• Community-acquired pneumonia: An overview  Journal Articles
• Comparing First- and Second-year Palivizumab Prophylaxis in Patients With Hemodynamically Significant Congenital Heart Disease in the CARESS Database (2005–2015)  Journal Articles
• Comparison of the Cost of Hospitalization for Respiratory Syncytial Virus Disease Versus Palivizumab Prophylaxis in Canadian Inuit Infants  Journal Articles
• Comparison of three cell-based drug screening platforms for HSV-1 infection  Journal Articles
• Cost-Effectiveness Analysis of Antiviral Treatments for HBeAg-Positive Chronic Hepatitis B in Canada  Journal Articles
• Cost-effectiveness of daclatasvir plus sofosbuvir-based regimen for treatment of hepatitis C virus genotype 3 infection in Canada  Journal Articles
• Cost-effectiveness of respiratory syncytial virus prophylaxis in premature infants less than 32 weeks gestational age in Turkey.  Journal Articles
• Countermeasures against viral diseases of farmed fish  Journal Articles
• Critically Ill Patients With 2009 Influenza A(H1N1) in Mexico  Journal Articles
• Current strategies in the prevention of respiratory syncytial virus disease  Journal Articles
• Cytomegalovirus infection of a cutaneous ulcer in a patient with ANCA-positive vasculitis  Journal Articles
• Decavanadate interactions with the elements of the SARS-CoV-2 spike protein highlight the potential role of electrostatics in disrupting the infectivity cycle  Journal Articles
• Decline in intrahepatic cccDNA and increase in immune cell reactivity after 12 weeks of antiviral treatment were associated with HBeAg loss.  Journal Articles
• Deep learning identifies synergistic drug combinations for treating COVID-19  Journal Articles
• Development of a novel bead-based multiplex PCR assay for combined subtyping and oseltamivir resistance genotyping (H275Y) of seasonal and pandemic H1N1 influenza A viruses  Journal Articles
• Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis  Journal Articles
• Discovery and Use of Long dsRNA Mediated RNA Interference to Stimulate Antiviral Protection in Interferon Competent Mammalian Cells  Journal Articles
• Discovery of potent antiviral (HSV-1) quinazolinones and initial structure-activity relationship studies  Journal Articles
• Diversity-Oriented Synthesis and Preliminary Biological Screening of Highly Substituted Five-Membered Lactones and Lactams Originating From an Allyboration of Aldehydes and Imines  Journal Articles
• Do Antiviral Medications Improve Symptoms in the Treatment of Bell’s Palsy?  Journal Articles
• Do Either Corticosteroids or Antiviral Agents Reduce the Risk of Long-Term Facial Paresis in Patients with New-Onset Bell's Palsy?  Journal Articles
• Does prophylaxis with palivizumab reduce hospitalisation rates for respiratory‐syncytial‐virus‐related infection in cystic fibrosis children less than 2 years of age?  Journal Articles
• Drug treatments for covid-19: living systematic review and network meta-analysis  Journal Articles
• Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient  Journal Articles
• Early Experience with Modified Dose Nirmatrelvir/Ritonavir in Dialysis Patients with Coronavirus Disease 2019  Journal Articles
• Early Treatment with Pegylated Interferon Lambda for Covid-19  Journal Articles
• Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs  Journal Articles
• Ebola Virus in West Africa: Waiting for the Owl of Minerva  Journal Articles
• Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19  Journal Articles
• Effect of conventional interferon‐α in patients with HBeAg‐positive chronic hepatitis B: a systematic review and meta‐analysis  Journal Articles
• Effect of remdesivir post hospitalization for COVID-19 infection from the randomized SOLIDARITY Finland trial  Journal Articles
• Efficacité et innocuité des agents antiviraux contre le SRAS-CoV-2, selon des données d’études sur la COVID-19 et d’autres infections virales aiguës : revue systématique et méta-analyse  Journal Articles
• Efficacy and Safety of Pegylated Interferon Alfa-2a or Alfa-2b Plus Ribavirin for the Treatment of Chronic Hepatitis C in Children and Adolescents: A Systematic Review and Meta-analysis  Journal Articles
• Efficacy and safety of a two‐drug direct‐acting antiviral agent regimen ruzasvir 180 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4, 5 or 6  Journal Articles
• Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis  Journal Articles
• Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials  Journal Articles
• Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial  Journal Articles
• Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus  Journal Articles
• Encephalitis  Journal Articles
• Establishment of real time allele specific locked nucleic acid quantitative PCR for detection of HBV YIDD (ATT) mutation and evaluation of its application.  Journal Articles
• Expanding Access to Treatment for Hepatitis C in Resource-Limited Settings: Lessons From HIV/AIDS  Journal Articles
• Expert consensus on palivizumab use for respiratory syncytial virus in developed countries  Journal Articles
• Exploring respiratory syncytial virus prophylaxis for children with all grades of bronchopulmonary dysplasia  Journal Articles
• Favourable IFNL3 Genotypes Are Associated with Spontaneous Clearance and Are Differentially Distributed in Aboriginals in Canadian HIV-Hepatitis C Co-Infected Individuals  Journal Articles
• Filamentous Phages as Building Blocks for Bioactive Hydrogels  Journal Articles
• First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005–2015)  Journal Articles
• Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders  Journal Articles
• Global molecular diversity of RSV – the “INFORM RSV” study  Journal Articles
• Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts  Journal Articles
• Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019  Journal Articles
• Glucocorticoid Receptors, Brain-Derived Neurotrophic Factor, Serotonin and Dopamine Neurotransmission are Associated with Interferon-Induced Depression  Journal Articles
• Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society  Journal Articles
• Hepatitis C Virus Testing of Persons Born During 1945–1965: Recommendations From the Centers for Disease Control and Prevention  Journal Articles
• Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants  Journal Articles
• Herpes Simplex Virus ICP0 Mutants Are Hypersensitive to Interferon  Journal Articles
• Herpes Simplex Virus ICP0 and ICP34.5 Counteract Distinct Interferon-Induced Barriers to Virus Replication  Journal Articles
• Herpes Zoster: Diagnostic, Therapeutic, and Preventive Approaches  Journal Articles
• High risk for RSV bronchiolitis in late preterms and selected infants affected by rare disorders: a dilemma of specific prevention  Journal Articles
• High-Throughput Screening Identifies Inhibitors of the SARS Coronavirus Main Proteinase  Journal Articles
• Higher dose versus lower dose of antiviral therapy in the treatment of herpes zoster infection in the elderly: a matched retrospective population-based cohort study  Journal Articles
• Hospitalization for Respiratory Syncytial Virus Illness in Down Syndrome Following Prophylaxis With Palivizumab  Journal Articles
• How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?  Journal Articles
• How much management is necessary? Sustaining the benefit of achieving a sustained virologic response to hepatitis C  Journal Articles
• Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19  Journal Articles
• IFN-γ treated monocyte/macrophage phagocytosis of red cells sensitized with IgG1 and IgG3 Anti-D containing identical immunoglobulin variable region genes  Journal Articles
• IL-15 and IFN-γ signal through the ERK pathway to inhibit HCV replication, independent of type I IFN signaling  Journal Articles
• Identification of a Novel Hepatitis C Virus Genotype From Punjab, India: Expanding Classification of Hepatitis C Virus Into 8 Genotypes  Journal Articles
• Identification of a Novel Pathway Essential for the Immediate-Early, Interferon-Independent Antiviral Response to Enveloped Virions  Journal Articles
• Identifying and Ensuring Optimal Care for All Children at Risk of Developing Serious Respiratory Syncytial Virus Disease: A Canadian Nurses’ Perspective  Journal Articles
• Impact of Asian Race on Response to Combination Therapy With Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C  Journal Articles
• Impact of using the International Risk Scoring Tool on the cost-utility of palivizumab for preventing severe respiratory syncytial virus infection in Canadian moderate-to-late preterm infants  Journal Articles
• In outpatients with COVID-19 during Omicron variant circulation, molnupiravir and nirmatrelvir–ritonavir improved outcomes  Journal Articles
• Increased Eligibility for Treatment of Chronic Hepatitis C Infection with Shortened Duration of Therapy: Implications for Access to Care and Elimination Strategies in Canada  Journal Articles
• Incremental Cost-Effectiveness Analysis of Intravenous Ganciclovir Versus Oral Ganciclovir in the Maintenance Treatment of Newly Diagnosed Cytomegalovirus Retinitis in Patients with AIDS  Journal Articles
• Induction of Innate Immune Responses in the Female Genital Tract: Friend or Foe of HIV‐1 Infection?  Journal Articles
• Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)  Journal Articles
• Influenza A/H1N1 septic shock in a patient with systemic lupus erythematosus. A case report  Journal Articles
• Influenza Promotes Collagen Deposition via αvβ6 Integrin-mediated Transforming Growth Factor β Activation  Journal Articles
• Influenza in patients with hematological malignancies: Experience at two comprehensive cancer centers  Journal Articles
• Inhibition of Warfarin Activity by Ribavirin  Journal Articles
• Interferon-β induced in female genital epithelium by HIV-1 glycoprotein 120 via Toll-like-receptor 2 pathway acts to protect the mucosal barrier  Journal Articles
• Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)  Journal Articles
• Isolation and Characterization of Novel Marine-Derived Actinomycete Taxa Rich in Bioactive Metabolites  Journal Articles
• Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group  Journal Articles
• Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study  Journal Articles
• Letter to the Editor  Journal Articles
• Liver transplant outcomes in HIV-infected patients: a systematic review and meta-analysis with synthetic cohort  Journal Articles
• Local Delivery of CpG Oligodeoxynucleotides Induces Rapid Changes in the Genital Mucosa and Inhibits Replication, but Not Entry, of Herpes Simplex Virus Type 2  Journal Articles
• Long Term Follow-Up of Patients with Chronic Hepatitis C Treated with Alpha Interferon  Journal Articles
• Management of Bell palsy: clinical practice guideline  Journal Articles
• Managing drug shortages during a pandemic: tocilizumab and COVID-19  Journal Articles
• Marijuana Use in Hepatitis C Infection does not Affect Liver Biopsy Histology or Treatment Outcomes  Journal Articles
• Massive air leak secondary to influenza B in a 7-year-old: A case report  Journal Articles
• Mixed‐Genotype HCV Direct Acting Antiviral Outcomes: A CANUHC Analysis  Journal Articles
• Modeling Hepatitis C Elimination Among People Who Inject Drugs in New Hampshire  Journal Articles
• Model‐Informed Drug Development for Anti‐Infectives: State of the Art and Future  Journal Articles
• Mood disorder associated with gastrointestinal and liver diseases: are there many challenges?  Journal Articles
• My Kingdom for a Denominator, or at Least Enough Data  Journal Articles
• NK cells require type I IFN receptor for antiviral responses during genital HSV-2 infection  Journal Articles
• Network meta-analysis of direct-acting antivirals in combination with peginterferon–ribavirin for previously untreated patients with hepatitis C genotype 1 infection  Journal Articles
• Novel therapy for asthma  Journal Articles
• ORAL VALACYCLOVIR IN THE TREATMENT OF ACUTE RETINAL NECROSIS SYNDROME  Journal Articles
• Oseltamivir for Treatment of Influenza in Healthy Adults: Pooled Trial Evidence and Cost-Effectiveness Model for Canada  Journal Articles
• Oseltamivir use amongst hospitalized patients infected with influenza  Journal Articles
• Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada)  Journal Articles
• Outcomes of Infants Receiving Palivizumab Prophylaxis for Respiratory Syncytial Virus in Canada and Italy  Journal Articles
• Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 1)  Journal Articles
• Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 2)  Journal Articles
• Palivizumab Adherence and Outcomes in Canadian Aboriginal Children  Journal Articles
• Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes  Journal Articles
• Palivizumab prophylaxis for respiratory syncytial virus in infants with cystic fibrosis: is there a need?  Journal Articles
• Pan-American Guidelines for the treatment of SARS-CoV-2/COVID-19: a joint evidence-based guideline of the Brazilian Society of Infectious Diseases (SBI) and the Pan-American Association of Infectious Diseases (API)  Journal Articles
• Paranoid psychosis and cognitive impairment associated with hepatitis C antiviral therapy  Journal Articles
• Peginterferon Plus Ribavirin for Chronic Hepatitis C in Patients With Human Immunodeficiency Virus  Journal Articles
• Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: Systematic review of randomized trials  Journal Articles
• Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C  Journal Articles
• Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial  Journal Articles
• Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C  Journal Articles
• Pegylated Interferon Lambda for Covid-19  Journal Articles
• Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research  Journal Articles
• Postexposure prophylaxis for common infectious diseases.  Journal Articles
• Predictors of Recurrent Herpes Simplex Virus Keratitis  Journal Articles
• Preemptive Strategy for Ganciclovir Administration Against Cytomegalovirus in Liver Transplantation Recipients  Journal Articles
• Prophylaxis for COVID-19: a systematic review  Journal Articles
• Quality and methodology of clinical practice guidelines on antiviral pharmacotherapy for COVID-19 during the early phase of the pandemic  Journal Articles
• R430: A potent inhibitor of DNA and RNA viruses  Journal Articles
• REVIEW ARTICLE: The Role of Toll‐Like Receptor Ligands/Agonists in Protection Against Genital HSV‐2 Infection  Journal Articles
• Real-world effectiveness of peginterferon α-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studies  Journal Articles
• Real‐world impact of direct acting antiviral therapy on health‐related quality of life in HIV/Hepatitis C co‐infected individuals  Journal Articles
• Rebuttal: palivizumab for the prevention of respiratory syncytial virus infection.  Journal Articles
• Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity  Journal Articles
• Regulation of kynurenine biosynthesis during influenza virus infection  Journal Articles
• Reliability and Validity of the HIV Disability Questionnaire (HDQ) with Adults Living with HIV in the United States  Journal Articles
• Remdesivir for severe covid-19: a clinical practice guideline  Journal Articles
• Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial  Journal Articles
• Respiratory Syncytial Virus Immunoprophylaxis with Palivizumab: 12-Year Observational Study of Usage and Outcomes in Canada  Journal Articles
• Respiratory Syncytial Virus Prophylaxis in Infants With Congenital Diaphragmatic Hernia in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab, 2005–2017  Journal Articles
• Respiratory Syncytial Virus Prophylaxis in Neurologic and Muscular Disorders in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab  Journal Articles
• Respiratory hospitalizations and respiratory syncytial virus prophylaxis in special populations  Journal Articles
• Respiratory illness and respiratory syncytial virus hospitalization in infants with a tracheostomy following prophylaxis with palivizumab  Journal Articles
• Respiratory syncytial virus (RSV) infection in children with medical complexity  Journal Articles
• Respiratory syncytial virus nosocomial outbreak in neonatal intensive care: A review of the incidence, management, and outcomes  Journal Articles
• Respiratory syncytial virus prophylaxis for children with chronic lung disease: have we got the criteria right?  Journal Articles
• Respiratory syncytial virus prophylaxis in children with cardiac disease: a retrospective single-centre study  Journal Articles
• Respiratory syncytial virus prophylaxis in cystic fibrosis: the Canadian registry of palivizumab data (2005–2016)  Journal Articles
• Respiratory syncytial virus prophylaxis in infants with congenital airway anomalies compared to standard indications and complex medical disorders  Journal Articles
• Respiratory-Related Hospitalizations following Prophylaxis in the Canadian Registry for Palivizumab (2005–2012) Compared to Other International Registries  Journal Articles
• Responder Interferon λ Genotypes Are Associated With Higher Risk of Liver Fibrosis in HIV–Hepatitis C Virus Coinfection  Conferences
• Retreatment with Pegylated Interferon Alpha-2a and Ribavirin in Patients with Chronic Hepatitis C Who Have Relapsed or Not Responded to a First Course of Pegylated Interferon-Based Therapy  Journal Articles
• Risk of Acute Kidney Injury From Oral Acyclovir: A Population-Based Study  Journal Articles
• Risk of Cardiovascular Disease Associated with HCV and HBV Coinfection among Antiretroviral-Treated HIV-Infected Individuals  Journal Articles
• Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for prevention  Journal Articles
• Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian Registry  Journal Articles
• Seasonal Respiratory Syncytial Virus Prophylaxis Based on Predetermined Dates Versus Regional Surveillance Data  Journal Articles
• Severe late-onset multisystem cytomegalovirus infection in a premature neonate previously treated for congenital infection  Journal Articles
• Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1)  Journal Articles
• Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2, Update Alert 3)  Journal Articles
• Sirolimus and low-dose tacrolimus with antibody induction in kidney transplantation: preliminary results of a pilot study  Conferences
• Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis  Journal Articles
• Suicide risk in hepatitis C and during interferon-alpha therapy: a review and clinical update  Journal Articles
• Susceptibility of Human Female Primary Genital Epithelial Cells to Herpes Simplex Virus, Type-2 and the Effect of TLR3 Ligand and Sex Hormones on Infection1  Journal Articles
• Synergistic binding of inhibitors to the protease from HIV type 1  Journal Articles
• Synthesis of non-nucleoside anti-viral cyclopropylcarboxacyl hydrazones and initial anti-HSV-1 structure-activity relationship studies  Journal Articles
• TAKE-HOME MESSAGE  Journal Articles
• Targeting PI3K-p110α Suppresses Influenza Virus Infection in Chronic Obstructive Pulmonary Disease  Journal Articles
• Taurocholic acid inhibits the response to interferon-α therapy in patients with HBeAg-positive chronic hepatitis B by impairing CD8+ T and NK cell function.  Journal Articles
• The Genesis and Spread of Reassortment Human Influenza A/H3N2 Viruses Conferring Adamantane Resistance  Journal Articles
• The Herpes Simplex Virus ICP0 RING Finger Domain Inhibits IRF3- and IRF7-Mediated Activation of Interferon-Stimulated Genes  Journal Articles
• The Moral Imperative to Include Pregnant Women in Clinical Trials of Interventions for COVID-19  Journal Articles
• The Nitric Oxide Pathway Provides Innate Antiviral Protection in Conjunction with the Type I Interferon Pathway in Fibroblasts  Journal Articles
• The Real‐Life Effectiveness of Palivizumab for Reducing Hospital Admissions for Respiratory Syncytial Virus in Infants Residing in Nunavut  Journal Articles
• The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19  Journal Articles
• The Thiazole-5-Carboxamide GPS491 Inhibits HIV-1, Adenovirus, and Coronavirus Replication by Altering RNA Processing/Accumulation  Journal Articles
• The cancer patient with chronic pain due to herpes zoster  Journal Articles
• The cost effectiveness of palivizumab in congenital heart disease: a review of the current evidence  Journal Articles
• The cost effectiveness of palivizumab in term Inuit infants in the Eastern Canadian Arctic  Journal Articles
• The cost effectiveness of palivizumab: a systematic review of the evidence  Journal Articles
• The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32–35 weeks: a Canadian-based analysis  Journal Articles
• The discovery and characterization of a novel scaffold as a potent hepatitis C virus inhibitor  Journal Articles
• The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials  Journal Articles
• The health impact of delaying direct‐acting antiviral treatment for chronic hepatitis C: A decision‐analytic approach  Journal Articles
• The impact of prophylaxis on paediatric intensive care unit admissions for RSV infection: a retrospective, single-centre study  Journal Articles
• The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect  Journal Articles
• The unfulfilled promise of efficacy trials in HIV/hepatitis C co-infected patients  Journal Articles
• Therapeutic options for external genital warts.  Journal Articles
• Treatment Outcomes of Treatment-Naïve Hepatitis C Patients Co-Infected with HIV: A Systematic Review and Meta-Analysis of Observational Cohorts  Journal Articles
• Treatment for First Cytomegalovirus Infection Post–Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir  Journal Articles
• Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline  Journal Articles
• Treatment responses in Asians and Caucasians with chronic hepatitis C infection  Journal Articles
• Truncated ring-A amaryllidaceae alkaloid modulates the host cell integrated stress response, exhibiting antiviral activity to HSV-1 and SARSCoV-2  Journal Articles
• Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)  Journal Articles
• Use of Oseltamivir During Influenza Outbreaks in Ontario Nursing Homes, 1999–2000  Journal Articles
• Use of novel antithrombotic agents for COVID‐19: Systematic summary of ongoing randomized controlled trials  Journal Articles
• Viral hepatitis elimination: a challenge, but within reach  Journal Articles
• Viral infections in the elderly  Journal Articles
• WHO Living Guidelines on antivirals for COVID-19 are evidence-based  Journal Articles
• WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus  Journal Articles
• Wastewater-based surveillance identifies start to the pediatric respiratory syncytial virus season in two cities in Ontario, Canada  Journal Articles
• Which trial do we need? Randomized, placebo-controlled trial of antiviral treatment in patients hospitalized for influenza  Journal Articles
• Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-CoV-2 infection?  Journal Articles
• Zanamivir Use During Transmission of Amantadine-Resistant Influenza A in a Nursing Home  Conferences